Elsevier

Science of The Total Environment

Volume 423, 15 April 2012, Pages 151-161
Science of The Total Environment

Distribution of blood concentrations of persistent organic pollutants in a representative sample of the population of Barcelona in 2006, and comparison with levels in 2002

https://doi.org/10.1016/j.scitotenv.2012.02.001Get rights and content

Abstract

Introduction

POP biomonitoring programs are useful for exposure assessment, to analyze patterns, and to evaluate policies. However, population-representative surveys are scarce and heterogeneous. Reports on time trends in representative samples using the same methods are rare.

Objectives

To analyze the distribution of serum concentrations of 19 POPs in the general population of Barcelona city in 2006, and to compare it with the distribution in 2002.

Methods

231 participants in the Barcelona Health Survey were interviewed face-to-face, gave blood, and underwent a physical exam. Density plots (“POP Geoffrey Rose curves”) were used to represent the full population distribution of each compound.

Results

Eight POPs were each detected in > 80% of the study subjects: p,p′-DDT, p,p′-DDE, PCB congeners 118, 138, 153 and 180, HCB and β-HCH. The minimum number of POPs detected in one person was 5, and 72% of the population accumulated ≥ 10 compounds. p,p′-DDE and HCB showed the highest concentrations (median = 219 and 109 ng/g lipid, respectively). Concentrations decreased by 34–56% from 2002 to 2006. The decrease was similar in women and men, and in all age groups/birth cohorts. It was larger with increasing BMI; for p,p′-DDT, HCB and β-HCH the decrease in obese individuals was 31–44 percentage points larger than in subjects with normal weight. The distribution of POP concentrations was always switched towards higher values in women than men. POP levels also differed significantly by age, body mass index, weight gain, birth place and social class, but not by parity and breastfeeding. The two younger cohorts had a higher DDT/DDE ratio than the oldest cohort.

Conclusion

Although human POP contamination remains common in the city of Barcelona, concentrations decreased significantly in 4 years. Our approach suggests innovative ways to conceive, analyze and present results for other monitoring programs.

Highlights

► Eight of the 19 POPs analyzed were (each) detected in > 80% of the study subjects. ► The minimum number of POPs detected in one person was 5. ► There were large interindividual differences in concentrations. ► POP concentrations decreased 34–56% in Barcelona city in 4 years. ► Our “POP Geoffrey Rose curves” emphasize the population nature of the problem.

Introduction

Persistent organic pollutants (POPs) comprise a large variety of toxic substances such as hexachlorobenzene (HCB), hexachlorocyclohexanes (HCHs), dioxins, dichlorodiphenyltrichloroethane (DDT) and its metabolites (notably, dichlorodiphenyldichloroethene, DDE), and polychlorinated biphenyls (PCBs). POPs are highly lipophilic and resistant to degradation; they thus accumulate in adipose tissue and in organs such as liver, brain, or pancreas (WHO, 2003). Many human populations are exposed to POP mixtures over the lifecourse, usually at low doses (Luzardo et al., 2009). A variety of studies have shown that POPs may adversely influence health and well-being: they contribute to cause infertility, birth defects, learning disabilities, endocrine disruption, diabetes, several cancers, Alzheimer's and Parkinson's disease, and other neurological, gynecological and immunological disorders (Alonso-Magdalena et al., 2011, Casals-Casas and Desvergne, 2011, Diamanti-Kandarakis et al., 2009, Kaiser, 2005, La Merrill and Birnbaum, 2011, Schug, 2011, Soto and Sonnenschein, 2011, UNEP (United Nations Environment Programme), 2002). However, numerous uncertainties exist on the health effects of chronic exposure to POPs in the general population (Henkler and Luch, 2011, Hernández et al., 2009, Lee et al., 2009, Myers et al., 2009). To decrease such uncertainties and appropriately protect the health of citizens, better knowledge on the levels and trends of contamination of the population is essential.

Most POPs are presently targeted for elimination or reduction. Legal instruments as the Stockholm Convention encourage countries to integrate population-based surveillance of POP levels in humans within their health monitoring systems (Porta and Zumeta, 2002, UNEP (United Nations Environment Programme Chemicals), 2005). POP monitoring programs are useful for exposure assessment, to analyze trends and patterns of contamination, and to evaluate the effectiveness of policies aimed at decreasing exposure. However, worldwide, comprehensive monitoring of human contamination by POPs is scarce, fragmented and heterogeneous. Methodological characteristics of studies vary largely, including selection of participants, sociodemographic information, chemical and statistical methods, and frameworks for interpretation of results (Porta et al., 2008b, Porta et al., 2009a). For example, the full range of POP concentrations is often overlooked, and little attention is paid to the characteristics of the distribution of the concentrations (e.g., differences across subgroups in kurtosis, skewness, and coefficient of variation) (Porta et al., 2008b, Porta et al., 2010a). Also, national studies monitoring human exposure to POPs do not usually include data on parity and breastfeeding (Dewailly et al., 1996, Tajimi et al., 2004). Another example of a variable that is not usually collected in population biomonitoring studies is weight change, which may alter blood lipid levels and bias estimates of exposure to lipophilic compounds like POPs. As we shall see below, the influence of parity, breastfeeding and weight change was assessed in the present study.

As in other countries, in Spain most POPs were banned during the 1970s, and levels of some of them have decreased (Porta et al., 2008a). However, uncertainties abound, and the only two Spanish studies based on representative samples of a population detected a substantial number of compounds in over 85% of citizens (Zumbado et al., 2005, Porta et al., 2010b, Henríquez-Hernández et al., 2011, Porta et al., 2012). In 2006, the Public Health Agency of Barcelona conducted the fifth Barcelona Health Survey (BHS), which included a physical examination and, for the first time, blood drawing – explicitly conceived for POPs monitoring – in a sample of participants; serum concentrations of 19 POPs were thus determined in 231 subjects (Porta et al., 2009a). In 2002, POP concentrations were analyzed in the Catalan Health Survey (CHS); based on a representative sample of the population of Catalonia (Porta et al., 2010b), it included a subsample of individuals representative of the city of Barcelona. Therefore, for the first time in Spain, we could assess trends in POP levels in Barcelona measured in an identical way. Reports on POP time trends in representative samples using the same methods are also extremely rare worldwide.

The aim of the present study was, firstly, to analyze the distribution of serum concentrations of 19 POPs in the non-institutionalized adult population of Barcelona city, and its main socio-demographic predictors; and, secondly, to compare the concentrations of POPs analyzed in the BHS with the concentrations in individuals from Barcelona studied four years earlier in the CHS.

Section snippets

Study population and health interview survey

The study population of the Barcelona Health Survey of 2006 (BHS) has been described in detail elsewhere (Porta et al., 2009a, Rodríguez-Sanz et al., 2008). Briefly, at the end of the interview the study monitors offered BHS participants ≥ 15 years old to take part in the POP study (Porta et al., 2009a); the youngest person who actually participated in the POP study was 18 years old. Subsequently, a nurse personally interviewed each person who accepted to participate in the POP study, measured the

Results

Eight of the 19 POPs analyzed were each detected in > 80% of the study subjects: p,p′-DDT, p,p′-DDE, PCB congeners 118, 138, 153 and 180, HCB and β-HCH. p,p′-DDE was detected and quantified in all samples (Table 2, Fig. 1). The percentage of detection for the other 11 analytes ranged between 1% and 65% (Table 2 of Supplementary Material). Thus, all 19 POPs were detected. No individual was free from POPs: the smallest number detected in one person was 5 compounds, and the largest, 15 POPs. 72% of

Discussion

Eight POPs were each detected in > 80% of the study subjects, and no individual was free from POPs; the smallest number detected in one person was 5 compounds, while ten or more compounds were detected in 72% of the population. However, from 2002 to 2006 serum concentrations of POPs decreased 34–56% in Barcelona city (Porta et al., 2010b).

In the BHS a pattern of progressive “flattening” of the POP distributions with increasing age was also seen, as previously in the CHS (Porta et al., 2010b).

Conclusions

Although all POPs analyzed were banned decades ago, human contamination remains common in the city of Barcelona, as elsewhere. Eight of the 19 POPs analyzed were (each) detected in > 80% of the study subjects, the minimum number of POPs detected in one person was 5, and there were large interindividual differences in concentrations. However, POP concentrations decreased 34–56% in 4 years.

While scarce and heterogeneous worldwide, population-based surveys on the distribution of POP concentrations

Conflicts of interest

The authors declare they have no competing financial interests.

Acknowledgements

Supported in part by research grants from the Department of Health, Government of Catalonia; ‘Red temática de investigación cooperativa de centros en Cáncer’ (C03/10); ‘Red temática de investigación cooperativa de centros en Epidemiología y salud pública’ (C03/09); and CIBER de Epidemiología, Instituto de Salud Carlos III, Ministry of Health, Government of Spain. The authors gratefully acknowledge technical and scientific assistance provided by Joan Guix, Montserrat Guillén, Elisa Puigdomènech,

References (71)

  • J.O. Grimalt et al.

    An evaluation of the sexual differences in the accumulation of organochlorine compounds in children at birth and at the age of 4 years

    Environ Res

    (2010)
  • L. Hagmar et al.

    Intra-individual variations and time trends 1991–2001 in human serum levels of PCB, DDE and hexachlorobenzene

    Chemosphere

    (2006)
  • E. Hardell et al.

    Time trends of persistent organic pollutants in Sweden during 1993–2007 and relation to age, gender, body mass index, breast-feeding and parity

    Sci Total Environ

    (2010)
  • L.A. Henríquez-Hernández et al.

    Background levels of polychlorinated biphenyls in the population of the Canary Islands (Spain)

    Environ Res

    (2011)
  • L. Hernández et al.

    Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach

    Mutat Res

    (2009)
  • P. Jakszyn et al.

    Serum levels of organochlorine pesticides in healthy adults from five regions of Spain

    Chemosphere

    (2009)
  • G. Koppen et al.

    Persistent organochlorine pollutants in human serum of 50–65 years old women in the Flanders Environmental and Health Study (FLEHS). Part 1: concentrations and regional differences

    Chemosphere

    (2002)
  • B. Link et al.

    Biomonitoring of persistent organochlorine pesticides, PCDD/PCDFs and dioxin-like PCBs in blood of children from South West Germany (Baden-Wuerttemberg) from 1993 to 2003

    Chemosphere

    (2005)
  • O.P. Luzardo et al.

    Determinants of organochlorine levels detectable in the amniotic fluid of women from Tenerife Island (Canary Islands, Spain)

    Environ Res

    (2009)
  • J. Petrik et al.

    Serum PCBs and organochlorine pesticides in Slovakia: age, gender, and residence as determinants of organochlorine concentrations

    Chemosphere

    (2006)
  • M. Porta et al.

    Studies conducted in Spain on concentrations in humans of persistent toxic compounds

    Gac Sanit

    (2008)
  • M. Porta et al.

    Monitoring concentrations of persistent organic pollutants in the general population: the international experience

    Environ Int

    (2008)
  • M. Porta et al.

    Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids

    J Clin Epidemiol

    (2008)
  • M. Porta et al.

    Sociodemographic factors influencing participation in the Barcelona Health Survey study on serum concentrations of persistent organic pollutants

    Chemosphere

    (2009)
  • M. Porta et al.

    Correcting serum concentrations of organochlorine compounds by lipids: alternatives to the organochlorine/total lipids ratio

    Environ Int

    (2009)
  • M. Porta et al.

    Distribution of blood concentrations of persistent organic pollutants in a representative sample of the population of Catalonia

    Environ Int

    (2010)
  • C. Schroijen et al.

    Internal exposure to pollutants measured in blood and urine of Flemish adolescents in function of area of residence

    Chemosphere

    (2008)
  • J.C. Van Oostdam et al.

    Circumpolar maternal blood contaminant survey, 1994–1997 organochlorine compounds

    Sci Total Environ

    (2004)
  • M.B. Zubero et al.

    Serum levels of polychlorinated dibenzodioxins and dibenzofurans and PCBs in the general population living near an urban waste treatment plant in Biscay, Basque Country

    Chemosphere

    (2009)
  • M. Zumbado et al.

    Inadvertent exposure to organochlorine pesticides DDT and derivatives in people from the Canary Islands (Spain)

    Sci Total Environ

    (2005)
  • M.H. Aliyu et al.

    To breastfeed or not to breastfeed: a review of the impact of lactational exposure to polychlorinated biphenyls (PCBs) on infants

    J Environ Health

    (2010)
  • P. Alonso-Magdalena et al.

    Endocrine disruptors in the etiology of type 2 diabetes

    Nat Rev Endocrinol

    (2011)
  • P. Armitage et al.

    Statistical methods in medical research

    (2002)
  • D. Baris et al.

    Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients

    Cancer Epidemiol Biomarkers Prev

    (2000)
  • C. Casals-Casas et al.

    Endocrine disruptors: from endocrine to metabolic disruption

    Annu Rev Physiol

    (2011)
  • Cited by (67)

    View all citing articles on Scopus
    View full text